News
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide). The ...
6don MSN
Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...
In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide). The injectable prescription medicine is primarily used to treat type 2 ...
John Fetterman urged Trump to reverse his decision to pull a Biden-era proposal that would have made GLP-1 medications more ...
(Journal of Clinical Endocrinology & Metabolism) By December 2023, tirzepatide (Mounjaro, Zepbound ... a study published in PLOS Medicine. Sen. John Fetterman (D-Pa.) said taking tirzepatide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results